Cardlytics (CDLX) Operating Expenses (2017 - 2026)

Cardlytics has reported Operating Expenses for 10 years, with the latest figure at $42.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 36.95% year-over-year to $42.6 million; the trailing twelve-month figure through Mar 2026 stood at $301.7 million (down 33.09% YoY), and the FY2025 full-year result was $335.1 million, down 29.28% from the prior year.
• Operating Expenses for Q1 2026 stood at $42.6 million, down from $62.2 million in the prior quarter.
• The five-year high for Operating Expenses was $465.1 million in Q4 2022, with the low at $32.3 million in Q1 2022.
• Historically, Operating Expenses has averaged $120.2 million across 5 years, with a median of $85.4 million in 2024.
• Annual changes were most pronounced in 2022 — Operating Expenses jumped 336.92% — and 2023, when it sank 58.7%.
• Cardlytics' Operating Expenses stood at $465.1 million in 2022, then slumped by 58.7% to $192.1 million in 2023, then sank by 57.15% to $82.3 million in 2024, then declined by 24.45% to $62.2 million in 2025, then plunged by 31.51% to $42.6 million in 2026.
• The last three Operating Expenses figures came in at $42.6 million (Q1 2026), $62.2 million (Q4 2025), and $120.9 million (Q3 2025), per Business Quant data.